Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
The cost of treating cancer has risen to unprecedented levels, putting tremendous financial pressure on patients, payers, and society. Prior studies have documented the rising prices of cancer drugs at market entry, but less attention has been paid to trends in prices after market entry. The objective of this study was to examine post-entry trends in expenditures for recently FDA-approved orally administered anticancer drugs.
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
